摘要
利用放射性核素131I治疗弥漫性毒性甲状腺肿已经成为临床的主要方法之一。131I治疗剂量过小达不到治疗的目的 ,治疗剂量过大对患者和环境带来不必要的放射性暴露,特别是对于越来越多的年轻人接受放射性核素131I治疗,使131I导致的甲减对于患者生活质量的影响时间趋于长久。患者甲状腺体积(质量)是放射性核素131I治疗时计算投药量的重要参数,准确测量甲状腺体积是131I治疗的重要环节,也是评价疗效的有效指标之一。本文对甲状腺显像评估甲状腺体积的方法及影响因素进行综述。
The use of radionuclide 131I in treatment of diffuse toxic goiter has become one of the main clinical methods.Low dose 131I is not enough achieve the purpose of treatment,while overdose may cause excessive unnecessary radiation exposure for patients and environment,and influence upon the quality of life of the hypothyroidism patients,especially for the growing number of young patients who received 131I treatment.The thyroid volume（mass） is an important parameter in measuring dosage of radionuclide 131I treatment.Accurate measurement of thyroid volume is an important part in 131I treatment of hyperthyroidism,also one of the effective indicators for evaluation of therapeutic efficacy.The methods of assessing thyroid volume with thyroid imaging and the impact factors were reviewed in this article.
出处
《中国医学影像技术》
CSCD
北大核心
2011年第6期1295-1298,共4页
Chinese Journal of Medical Imaging Technology
